10-K - CERO THERAPEUTICS HOLDINGS, INC.
站内整理正文
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001213900-26-044040
Filing Date: 2026-04-15
Accepted: 2026-04-15 16:05:58
Documents: 111
Period of Report: 2025-12-31
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK : 0001870404 (see all company filings) EIN. : 871088814 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 10-K | Act: 34 | File No.: 001-40877 | Film No.: 26864181 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | ANNUAL REPORT | ea0285271-10k_cero.htm iXBRL | 10-K
2 | DESCRIPTION OF SECURITIES | ea028527101ex4-5.htm | EX-4.5
3 | CONSENT OF WOLF & COMPANY, P.C., THE REGISTRANT'S FORMER INDEPENDENT REGISTERED | ea028527101ex23-1.htm | EX-23.1
4 | CONSENT OF SALBERG & COMPANY, P.A., THE REGISTRANT'S INDEPENDENT REGISTERED PUBL | ea028527101ex23-2.htm | EX-23.2